Terumo Medical Corp.

Today, Terumo Medical Corporation develops, manufactures, exports, imports, markets, distributes, and sells a diverse portfolio of medical devices, supplies, and accessories and generates $280 million in annual sales. While some of our products and devices are produced in Japan, a growing portion of them are produced in Elkton, Maryland, including Pinnacle® Destination® guiding sheaths, Pinnacle® R/0 II sheaths, Terumo® insulin syringes, and CAPIJECT® micro-collection tubes. The manufacturing facility in Elkton spans over 321,000 square feet and utilizes automated processes with a quality system that is certified to be in compliance with the ISO 13485 Standard.

Terumo Medical Corporation offers its wide range of products through three business divisions: Terumo Interventional Systems, Terumo Medical Products, and Terumo Transfusion Products.

1972: Terumo Medical Corporation is founded under the name Kimble Terumo, Inc.

1980: The sales and distribution facility in Piscataway, New Jersey, opens; purchased Owens-Illinois Joint Venture Holdings (Elkton, MD) and name changed to Terumo Medical Corporation

1982: Opening of new Terumo Medical Corporation research and development facility in Elkton, Maryland

1983: CAPIJECT^® capillary blood collection tubes are designed, patented, and go on sale in the U.S.

1985: U.S. production of insulin syringes begins

1988: Completion of major manufacturing expansion in Elkton, Maryland

1990: New sales and marketing headquarter office opens in Somerset, New Jersey

1995: U.S. production of cardiovascular devices begins

1999: Sarns division of 3M is acquired and it becomes Terumo Cardiovascular Systems Corporation, a wholly-owned subsidiary of Terumo Medical Corporation

2005: Mission Medical is acquired

2006: MicroVention is acquired; Terumo Interventional Systems begins direct sales of its entire endovascular product line

Present: Produces a diverse portfolio of medical devices, supplies, and accessories